Neurodegenerative diseases like Alzheimer’s, Parkinson’s disease, etc., are the most pressing challenges of our time. According to the World Health Organization (WHO), more than 55 million people worldwide live with dementia, with nearly 10 million new cases reported annually.
These diseases don’t just take a toll on the patient’s quality of life but also make it harder for them to seek help. That’s where Neuroglee Health steps in.
This health-tech company blends neuroscience and technology to help patients and caregivers manage neurodegenerative diseases such as Alzheimer’s and other forms of dementia.
Let’s understand how Neuroglee Health is empowering patients, caregivers, and healthcare providers alike.
Neuroglee Health’s unique approach
Neuroglee Health moves away from a one-size-fits-all regime and adopts personalised, multi-domain care plans. Its approach leverages cutting-edge AI and digital therapeutics and combines them with neuroscience.
Its user-centric digital tools ensure patients get the right interventions at the right time. Moreover, it focuses on home-based care to make treatment more accessible and convenient.
The company’s platform enables:
- Personalized Care Plans: It tailors interventions to individual patients’ cognitive and functional profiles, and adapts as their conditions evolve.
- Remote Monitoring: It continuously tracks patients’ health metrics, provides valuable insights and enables timely adjustments to care plans.
- Caregiver Support: It includes resources and training for caregivers to empower them with tools and provide effective support.
- Clinical Integration: It seamlessly integrates with existing clinical workflows, ensuring that healthcare providers have access to actionable data.
Key products and programs
Neuroglee’s flagship product, Neuroglee Connect, enhances care for patients with mild cognitive impairment (MCI) and early-stage dementia. The platform uses AI-driven insights and combines cognitive stimulation exercises with behavioural health coaching.
Neuroglee provides a one-stop solution for:
- A physician-led virtual care team that can integrate with the patient’s existing care plans.
- Tech-backed assessments and diagnostic tests for accurate and actionable insights.
- A mobile app where patients can access personalised, multi-domain care regimens.
- Cognitive training and other neurodegenerative disease-related support services.
The company is also pioneering partnerships with healthcare organizations to embed its technology into broader care ecosystems. These collaborations create a continuum of care that bridges in-person clinical visits and at-home interventions for improved patient engagement and outcomes.
Its notable partnerships are with the Mayo Clinic, Nuvance Health, Memory & Movement Charlotte and the Centers for Medicare & Medicaid Services (CMS).
The role of data and AI
Neuroglee’s defining strength is its use of data. The company’s advanced AI algorithms analyse patient information to identify patterns and predict disease progression. This enables:
- Early intervention strategies
- Optimized therapy plans
- Reduced healthcare costs through targeted care
Moreover, Neuroglee adheres to stringent data privacy and security standards like HIPAA, AICPA SOC and ISO, to keep sensitive health information protected.
More about Neuroglee Health
Neuroglee Health was founded by Aniket Singh Rajput in 2020. His vision is to revolutionize cognitive healthcare and improve outcomes for patients with neurodegenerative disorders.
The company’s patient-first approach has led to impressive clinical results. It has raised $12.3 million from two funding rounds.
Challenges and the road ahead
While Neuroglee Health has made significant strides, challenges remain. Adoption of digital therapeutics in traditional healthcare settings can be slow. It is often hindered by regulatory and reimbursement hurdles.
To achieve a broader impact, Neuroglee must ensure equitable access to technology for diverse populations.
Looking ahead, Neuroglee is well-positioned to lead the charge in neurodegenerative care. For those navigating the difficult journey of neurodegenerative diseases, it represents a beacon of innovation and hope.
As the company continues to refine its solutions and expand its reach, its contributions could redefine how these diseases are managed.
